The currently available treatments for autoimmune diseases were not developed with a clear
knowledge of the mechanisms involved in the primum movens of the disease process,
namely the activation of autoreactive T cells. A new generation of immunosuppressive
agents that are potentially useful in the prevention and/or treatment of autoimmunity is being
fostered by recent progress in the understanding of antigen presentation to T cells. In this
article, contributed by the chairpersons of a recent workshop on the subjects, the potential of …